Myomo, Inc. (MYO) Presents at IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 Transcript

Operator

Good day, and welcome to the IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026. Our next presenting company is Myomo, Inc. [Operator Instructions]

I’d now like to turn the floor over to today’s host, Mr. Paul Gudonis, who is the Chairman and Chief Executive Officer of Myomo, Inc. Sir, you may begin.

Paul Gudonis
President, CEO & Chairman

Thank you, and good afternoon, everyone. It’s a pleasure to introduce Myomo to you, and as well for existing investors to provide an update on our business progress here. So let me start by first reviewing our safe harbor statement about any forward-looking statements over here. And then I’m going to cover the investment highlights at this point in the company.

At Myomo, we’re a wearable medical robotics company. We’ve created a new product category for a large unmet need, as you’ll see, we have the first mover advantage with a strong competitive position. We recently got Medicare reimbursements and new payer contracts, which expands patient access to our life-changing technology. We’ve got growing revenues from recurring patient sources as we’ve adjusted our go-to-market model. And we’ve got an attractive margin profile and opportunity for scale economics as our Chief Financial Officer, will review this afternoon.

So let’s start by the diagnoses that we are addressing. So we address arm and hand paralysis of the upper extremity, mostly caused due to injuries from stroke other nerve damage diseases and major diagnoses being stroke or cerebrovascular accidents. We got a blood clot or hemorrhage in the brain, which then damages the motor cortex, other parts of the brain leaving the individual with